— Know what they know.
Not Investment Advice
Also trades as: CLSN (NASDAQ) · $vol 0M · 0HUZ.L (LSE) · $vol 0M

IMNN NASDAQ

Imunon, Inc.
1W: -9.2% 1M: -17.9% 3M: -35.4% YTD: -67.6% 1Y: -75.6% 3Y: -91.6% 5Y: -99.4%
$1.28
-0.04 (-3.03%)
 
Weekly Expected Move ±7.9%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 22 · $5.4M mcap · 4M float · 3.61% daily turnover · Short 57% of daily vol

Balance Sheet Trends

Total Assets
$12M +26.5% ▲
5Y CAGR: -20.0%
Total Liabilities
$5M -4.5% ▼
5Y CAGR: -22.7%
Shareholders Equity
$7M +66.4% ▲
5Y CAGR: -17.6%
Cash & Investments
$9M +49.5% ▲
5Y CAGR: -12.5%
Total Debt
$1M -11.5% ▼
5Y CAGR: -30.5%
Net Debt
-$8M -64.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$20M$11M$6M$6M$9M
Short-Term Investments$30M$21M$10M$0$0
Cash & ST Investments$49M$33M$16M$6M$9M
Net Receivables$109K$129K$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$4M$3M$2M$2M
Total Current Assets$52M$37M$18M$8M$11M
Property, Plant & Equip.$1M$704K$2M$2M$2M
Goodwill & Intangibles$13M$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$6M$5M$50K$50K$0
Total Non-Current Assets$22M$7M$4M$2M$2M
Total Assets$74M$44M$22M$10M$12M
— Liabilities —
Accounts Payable$3M$4M$4M$1M$0
Short-Term Debt$0$1M$0$0$406K
Deferred Revenue$500K$0$0$0$0
Other Current Liabilities$0$0$0$0$4M
Total Current Liabilities$7M$10M$7M$5M$5M
Long-Term Debt$6M$5M$0$0$602K
Other Non-Current Liab.$5M$0$0$0$0
Total Non-Current Liabilities$11M$5M$1M$687K$602K
Total Liabilities$18M$15M$9M$5M$5M
— Equity —
Common Stock$58K$74K$94K$145K$34K
Retained Earnings-$333M-$369M-$388M-$407M-$421M
Accumulated OCI-$8K$26K$61K$0$0
Total Stockholders Equity$56M$29M$13M$4M$7M
Total Liabilities & Equity$74M$44M$22M$10M$12M
— Key Metrics —
Total Debt$7M$6M$2M$1M$1M
Net Debt-$13M-$5M-$4M-$5M-$8M
Total Investments$30M$21M$10M$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms